197 related articles for article (PubMed ID: 33313821)
1. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Moradi PW; Sussman-Straus GE; Naing E; Kovanda LL; Finkelman MA; Walsh TJ
Med Mycol; 2021 Feb; 59(2):189-196. PubMed ID: 33313821
[TBL] [Abstract][Full Text] [Related]
2. In vitro combination therapy with isavuconazole against Candida spp.
Katragkou A; McCarthy M; Meletiadis J; Hussain K; Moradi PW; Strauss GE; Myint KL; Zaw MH; Kovanda LL; Petraitiene R; Roilides E; Walsh TJ; Petraitis V
Med Mycol; 2017 Nov; 55(8):859-868. PubMed ID: 28204571
[TBL] [Abstract][Full Text] [Related]
3. Posaconazole Alone and in Combination with Caspofungin for Treatment of Experimental
Petraitiene R; Petraitis V; Maung BW; Naing E; Kavaliauskas P; Walsh TJ
J Fungi (Basel); 2020 Mar; 6(1):. PubMed ID: 32150900
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
[TBL] [Abstract][Full Text] [Related]
5. In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.
Katragkou A; McCarthy M; Meletiadis J; Petraitis V; Moradi PW; Strauss GE; Fouant MM; Kovanda LL; Petraitiene R; Roilides E; Walsh TJ
Antimicrob Agents Chemother; 2014 Nov; 58(11):6934-7. PubMed ID: 25136021
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Petraitis V; Petraitiene R; McCarthy MW; Kovanda LL; Zaw MH; Hussain K; Shaikh N; Maung BBW; Sekhon NK; Hope WW; Walsh TJ
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696236
[TBL] [Abstract][Full Text] [Related]
7. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
Deng S; de Hoog GS; Badali H; Yang L; Najafzadeh MJ; Pan B; Curfs-Breuker I; Meis JF; Liao W
Antimicrob Agents Chemother; 2013 Apr; 57(4):1974-7. PubMed ID: 23380718
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
Chowdhary A; Hagen F; Curfs-Breuker I; Madrid H; de Hoog GS; Meis JF
Antimicrob Agents Chemother; 2015 Oct; 59(10):6642-5. PubMed ID: 26239995
[TBL] [Abstract][Full Text] [Related]
10. Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β-d-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Naing E; Kavaliauskas P; Barat S; Borroto-Esoda K; Azie N; Angulo D; Walsh TJ
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179521
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with isavuconazole of subcutaneous phaeohyphomycosis in a kidney transplant recipient.
Dalla Gasperina D; Lombardi D; Rovelli C; Di Rosa Z; Lepera V; Baj A; Nava A; Lombardi G; Grossi PA
Transpl Infect Dis; 2019 Dec; 21(6):e13197. PubMed ID: 31617282
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Gradient Concentration Strip Method for Antifungal Susceptibility Testing of Isavuconazole and Comparators for
Vidal P; Schwarz P; Dannaoui E
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358578
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
Shivaprakash MR; Geertsen E; Chakrabarti A; Mouton JW; Meis JF
Mycoses; 2011 Sep; 54(5):e583-9. PubMed ID: 21518026
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Petraitis V; Petraitiene R; Moradi PW; Strauss GE; Katragkou A; Kovanda LL; Hope WW; Walsh TJ
Antimicrob Agents Chemother; 2016 May; 60(5):2718-26. PubMed ID: 26883703
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.
Petraitiene R; Petraitis V; Hope WW; Mickiene D; Kelaher AM; Murray HA; Mya-San C; Hughes JE; Cotton MP; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4121-9. PubMed ID: 18779361
[TBL] [Abstract][Full Text] [Related]
16. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
17. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Marty FM; Ostrosky-Zeichner L; Cornely OA; Mullane KM; Perfect JR; Thompson GR; Alangaden GJ; Brown JM; Fredricks DN; Heinz WJ; Herbrecht R; Klimko N; Klyasova G; Maertens JA; Melinkeri SR; Oren I; Pappas PG; Ráčil Z; Rahav G; Santos R; Schwartz S; Vehreschild JJ; Young JH; Chetchotisakd P; Jaruratanasirikul S; Kanj SS; Engelhardt M; Kaufhold A; Ito M; Lee M; Sasse C; Maher RM; Zeiher B; Vehreschild MJGT;
Lancet Infect Dis; 2016 Jul; 16(7):828-837. PubMed ID: 26969258
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Badali H; Khodavaisy S; Fakhim H; de Hoog GS; Meis JF; Chowdhary A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7818-22. PubMed ID: 26369976
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans.
Najafzadeh MJ; Sutton DA; Keisari MS; Zarrinfar H; de Hoog GS; Chowdhary A; Meis JF
Antimicrob Agents Chemother; 2014 Sep; 58(9):5629-31. PubMed ID: 25001309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
